Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
What each said, in their own words
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
ECHAMP, the European Coalition on Homeopathic & Anthroposophic Medicinal Products, represents the majority of the companies active in the production and distribution of those products in the EU. We endorse the rights of more than 110 million patients and consumers in the EU to have easy and comprehensive access to reliable homeopathic and anthroposophic medicinal products which meet the highest standards of quality…
BEUC supports the European Commission’s initiative to evaluate and revise the general pharmaceutical legislation to improve access to medicines. We agree with the main gaps identified in the roadmap and corrective measures, but have additional recommendations. These are the most pressing issues and necessary changes for consumers: Unmet medical needs: Antimicrobial resistance is a global public health-threat.
ECHAMP, the European Coalition on Homeopathic and Anthroposophic Medicinal Products, represents an EU-based industry that has been serving the European market for decades. EU legislation for homeopathic medicinal products has deep roots in their broad use in the Member States; the EU being the global centre of expertise in manufacturing, quality standards and regulation of this industry.
ECHAMP, the European Coalition on Homeopathic and Anthroposophic Medicinal Products, represents an EU-based industry that has been serving the European market for decades. EU legislation for homeopathic medicinal products has deep roots in their broad use in the Member States; the EU being the global centre of expertise in manufacturing, quality standards and regulation of this industry.
The European Commission proposal for a revised EUs pharmaceutical legislation is a step in the right direction as it includes recommendations from BEUC on ways to improve access to medicines in Europe. We strongly support measures to increase transparency on public funding for biomedical research, facilitate the development of medicines by non-profit entities, and enhance EU cooperation and action in the prevention…
ECHAMP welcomes and supports this important initiative, which will be an essential cornerstone for the Pharmaceutical Strategy. We are pleased to see that the proposal emphasizes the importance of allowing patients and citizens control over their own health data and of exploring how to facilitate the inclusion of citizen-generated data.
BEUC, The European Consumer Organisation appreciates the opportunity to provide input to the European Commission’s ongoing evaluation of the need for a legislative proposal on a European Health Data Space. We consider that the evaluation provides a timely opportunity to ensure that sensitive data of European patients and consumers used for scientific advancements is well protected and serves societal interests.
Take this comparison with you
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.